New Chemotypes for the Inhibition of (p)ppGpp Synthesis in the Quest for New Antimicrobial Compounds

Antimicrobial resistance (AMR) poses a serious threat to our society from both the medical and economic point of view, while the antibiotic discovery pipeline has been dwindling over the last decades. Targeting non-essential bacterial pathways, such as those leading to antibiotic persistence, a bact...

Full description

Bibliographic Details
Main Authors: Crescenzo Coppa, Luca Sorrentino, Monica Civera, Marco Minneci, Francesca Vasile, Sara Sattin
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/27/10/3097
_version_ 1797497484750094336
author Crescenzo Coppa
Luca Sorrentino
Monica Civera
Marco Minneci
Francesca Vasile
Sara Sattin
author_facet Crescenzo Coppa
Luca Sorrentino
Monica Civera
Marco Minneci
Francesca Vasile
Sara Sattin
author_sort Crescenzo Coppa
collection DOAJ
description Antimicrobial resistance (AMR) poses a serious threat to our society from both the medical and economic point of view, while the antibiotic discovery pipeline has been dwindling over the last decades. Targeting non-essential bacterial pathways, such as those leading to antibiotic persistence, a bacterial bet-hedging strategy, will lead to new molecular entities displaying low selective pressure, thereby reducing the insurgence of AMR. Here, we describe a way to target (p)ppGpp (guanosine tetra- or penta-phosphate) signaling, a non-essential pathway involved in the formation of persisters, with a structure-based approach. A superfamily of enzymes called RSH (RelA/SpoT Homolog) regulates the intracellular levels of this alarmone. We virtually screened several fragment libraries against the (p)ppGpp synthetase domain of our RSH chosen model Rel<i><sub>Seq</sub></i>, selected three main chemotypes, and measured their interaction with Rel<i><sub>Seq</sub></i> by thermal shift assay and STD-NMR. Most of the tested fragments are selective for the synthetase domain, allowing us to select the aminobenzoic acid scaffold as a hit for lead development.
first_indexed 2024-03-10T03:19:52Z
format Article
id doaj.art-1f1274a59fe44197b3929f2e7386b8a6
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-10T03:19:52Z
publishDate 2022-05-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-1f1274a59fe44197b3929f2e7386b8a62023-11-23T12:21:00ZengMDPI AGMolecules1420-30492022-05-012710309710.3390/molecules27103097New Chemotypes for the Inhibition of (p)ppGpp Synthesis in the Quest for New Antimicrobial CompoundsCrescenzo Coppa0Luca Sorrentino1Monica Civera2Marco Minneci3Francesca Vasile4Sara Sattin5Dipartimento di Chimica, Università degli Studi di Milano, Via C. Golgi, 19, 20133 Milano, ItalyDipartimento di Chimica, Università degli Studi di Milano, Via C. Golgi, 19, 20133 Milano, ItalyDipartimento di Chimica, Università degli Studi di Milano, Via C. Golgi, 19, 20133 Milano, ItalyDipartimento di Chimica, Università degli Studi di Milano, Via C. Golgi, 19, 20133 Milano, ItalyDipartimento di Chimica, Università degli Studi di Milano, Via C. Golgi, 19, 20133 Milano, ItalyDipartimento di Chimica, Università degli Studi di Milano, Via C. Golgi, 19, 20133 Milano, ItalyAntimicrobial resistance (AMR) poses a serious threat to our society from both the medical and economic point of view, while the antibiotic discovery pipeline has been dwindling over the last decades. Targeting non-essential bacterial pathways, such as those leading to antibiotic persistence, a bacterial bet-hedging strategy, will lead to new molecular entities displaying low selective pressure, thereby reducing the insurgence of AMR. Here, we describe a way to target (p)ppGpp (guanosine tetra- or penta-phosphate) signaling, a non-essential pathway involved in the formation of persisters, with a structure-based approach. A superfamily of enzymes called RSH (RelA/SpoT Homolog) regulates the intracellular levels of this alarmone. We virtually screened several fragment libraries against the (p)ppGpp synthetase domain of our RSH chosen model Rel<i><sub>Seq</sub></i>, selected three main chemotypes, and measured their interaction with Rel<i><sub>Seq</sub></i> by thermal shift assay and STD-NMR. Most of the tested fragments are selective for the synthetase domain, allowing us to select the aminobenzoic acid scaffold as a hit for lead development.https://www.mdpi.com/1420-3049/27/10/3097AMRpersisters(p)ppGppfragment screeningthermal shift assaySTD-NMR
spellingShingle Crescenzo Coppa
Luca Sorrentino
Monica Civera
Marco Minneci
Francesca Vasile
Sara Sattin
New Chemotypes for the Inhibition of (p)ppGpp Synthesis in the Quest for New Antimicrobial Compounds
Molecules
AMR
persisters
(p)ppGpp
fragment screening
thermal shift assay
STD-NMR
title New Chemotypes for the Inhibition of (p)ppGpp Synthesis in the Quest for New Antimicrobial Compounds
title_full New Chemotypes for the Inhibition of (p)ppGpp Synthesis in the Quest for New Antimicrobial Compounds
title_fullStr New Chemotypes for the Inhibition of (p)ppGpp Synthesis in the Quest for New Antimicrobial Compounds
title_full_unstemmed New Chemotypes for the Inhibition of (p)ppGpp Synthesis in the Quest for New Antimicrobial Compounds
title_short New Chemotypes for the Inhibition of (p)ppGpp Synthesis in the Quest for New Antimicrobial Compounds
title_sort new chemotypes for the inhibition of p ppgpp synthesis in the quest for new antimicrobial compounds
topic AMR
persisters
(p)ppGpp
fragment screening
thermal shift assay
STD-NMR
url https://www.mdpi.com/1420-3049/27/10/3097
work_keys_str_mv AT crescenzocoppa newchemotypesfortheinhibitionofpppgppsynthesisinthequestfornewantimicrobialcompounds
AT lucasorrentino newchemotypesfortheinhibitionofpppgppsynthesisinthequestfornewantimicrobialcompounds
AT monicacivera newchemotypesfortheinhibitionofpppgppsynthesisinthequestfornewantimicrobialcompounds
AT marcominneci newchemotypesfortheinhibitionofpppgppsynthesisinthequestfornewantimicrobialcompounds
AT francescavasile newchemotypesfortheinhibitionofpppgppsynthesisinthequestfornewantimicrobialcompounds
AT sarasattin newchemotypesfortheinhibitionofpppgppsynthesisinthequestfornewantimicrobialcompounds